Sinew Pharma Inc. (TPEX:6634)

Sinew Pharma Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 7, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	3,900	2,792	3,392	4,798	7,326	5,659
Market Cap Growth	24.70%	-17.69%	-29.30%	-34.51%	29.47%	19.05%
Enterprise Value	2,863	1,707	2,185	3,468	5,895	4,354
Last Close Price	54.70	39.15	47.55	67.70	105.00	82.00
PS Ratio	82968.18	59405.82	-	-	22335.55	908.45
PB Ratio	3.57	2.56	2.83	3.63	5.02	3.61
P/TBV Ratio	3.62	2.60	2.89	3.73	5.22	3.77
EV/Sales Ratio	-	36314.06	-	-	17973.83	699.01
Debt / Equity Ratio	0.01	0.01	0.00	0.01	0.01	0.00
Net Debt / Equity Ratio	-0.95	-0.95	-0.97	-0.96	-0.95	-0.94
Net Debt / EBITDA Ratio	8.16	8.16	7.98	7.74	10.79	20.06
Net Debt / FCF Ratio	10.81	10.81	10.88	10.11	13.98	24.90
Asset Turnover	0	0	-	-	0	0.01
Quick Ratio	42.23	42.23	43.43	36.78	60.54	99.08
Current Ratio	42.28	42.28	43.46	36.81	60.56	99.36
Return on Equity (ROE)	-10.81%	-10.81%	-11.93%	-12.29%	-9.26%	-9.14%
Return on Assets (ROA)	-7.44%	-7.44%	-8.15%	-8.17%	-6.04%	-5.79%
Return on Capital Employed (ROCE)	-12.70%	-12.70%	-14.10%	-14.00%	-10.10%	-6.00%
Earnings Yield	-3.17%	-4.43%	-4.43%	-3.56%	-1.91%	-1.62%
FCF Yield	-2.46%	-3.44%	-3.13%	-2.61%	-1.35%	-1.05%
Buyback Yield / Dilution	0.37%	0.37%	-1.21%	-1.68%	-16.47%	-19.41%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.